Albuterol Sulfate Aerosol, Metered
Product Images NDC 68071-4940

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 68071-4940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 4940 2)

Pdp (68071 4940 2)
This appears to be a medication label for Albuterol Sulfate HFA produced by Care Pharmaceuticals, Inc. It is important to keep the medication away from children and it requires a prescription. Each inhalation delivers 108 mg of Albuterol, which is equivalent to 0 mg of Sulfafe. It is recommended to call a doctor for medical advice about side effects and report them to the FDA. The medication should be stored at temperatures between 59-77°F.*
FDA Label Image

Chemical Structure (Albuterol Sulfate Hfa N021457 1)

FDA Label Image

Figure F (Albuterol Sulfate Hfa N021457 10)

FDA Label Image

Figure G (Albuterol Sulfate Hfa N021457 11)

FDA Label Image

Figure H (Albuterol Sulfate Hfa N021457 12)

FDA Label Image

Figure I (Albuterol Sulfate Hfa N021457 13)

FDA Label Image

Figure J (Albuterol Sulfate Hfa N021457 14)

FDA Label Image

Figure K (Albuterol Sulfate Hfa N021457 15)

FDA Label Image

Day 1 Image (Albuterol Sulfate Hfa N021457 2)

Day 1 Image (Albuterol Sulfate Hfa N021457 2)
This appears to be a chart or table with data related to a study comparing the effects of Albuterol Sulfate HFA Inhalation Aerosol, Placebo HFA Inhalation Aerosol, and a Marketed HFA-134a Albuterol Inhaler on the change in FEV (or forced expiratory volume) over time. It includes sample sizes for each group and a measure of time in hours, but without more context it is not possible to determine the specifics of the study or its significance.*
FDA Label Image

Day 43 Image (Albuterol Sulfate Hfa N021457 3)

Day 43 Image (Albuterol Sulfate Hfa N021457 3)
This appears to be a chart or graph with data related to the use of Albuterol Sulfate HFA Inhalation Aerosol, as well as Placebo and Marketed HFA-134a Albuterol Inhaler. The chart shows the percentage change in FEV (forced expiratory volume) over time in hours. No additional context is provided, making it difficult to provide a more detailed description or interpretation of the data.*
FDA Label Image

Teva Logo (Albuterol Sulfate Hfa N021457 4)

FDA Label Image

Figure A (Albuterol Sulfate Hfa N021457 5)

Figure A (Albuterol Sulfate Hfa N021457 5)
The text describes the components of a metal canister that includes a cap, mouthpiece, and plastic actuator. The purpose of the canister is not mentioned.*
FDA Label Image

Figure B (Albuterol Sulfate Hfa N021457 6)

FDA Label Image

Figure C (Albuterol Sulfate Hfa N021457 7)

FDA Label Image

Figure D (Albuterol Sulfate Hfa N021457 8)

FDA Label Image

Figure E (Albuterol Sulfate Hfa N021457 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.